Elevated levels of IL-1, IL-6, and TNF-α in LPP may impair TG clearance by inhibiting lipoprotein lipase activity and reducing apoprotein-E levels, thus contributing to dyslipidemia [25]. This evidence concerns the gene LPL and metabolic syndrome.